Shockwave Medical introducing more efficient IVL catheter to US market at TCT 2023
Shockwave Medical, the California-based healthcare technology company known for its intravascular lithotripsy (IVL) technology, will be displaying its newest catheter at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 meeting in San Francisco.
The Shockwave C2+ Coronary IVL catheter includes new updates that help it provide 50% more pulses per catheter than Shockwave’s previous offering, the Shockwave C2 Coronary IVL catheter. This could help interventional cardiologists save a significant amount of money over time as the company’s IVL technology grows more and more popular in the years ahead.
“The enhancements of Shockwave C2+ will be an added benefit of IVL for optimally treating complex calcium, including more diffuse disease, as well as nodular and thick, eccentric calcium,” Richard Shlofmitz, MD, chairman of the department of cardiology at St. Francis Hospital in Roslyn, New York, said in a prepared statement. Shlofmitz performed the first U.S. commercial case with the device.
“When additional pulses are added to the existing intuitive catheter design and simple-to-use system that are foundational to the success of Shockwave IVL, the result is an updated catheter that can enhance workflow and improve procedural efficiency,” he added.
The full commercial launch of the Shockwave C2+ Coronary IVL catheter is planned for early November 2023.
Even beyond this announcement, Shockwave’s IVL capabilities will play a key role at TCT 2023. The company’s technology are involved in multiple studies that will be presented at the big show in San Francisco:
Monday, Oct. 23:
TCT WorldLink Latin America Featured Clinical Science: Complex Coronary Intervention
- Presentation Title: Shock India Registry: Multicenter Registry of Coronary IVL in Calcified Coronary Arteries in Real-World Indian Patient Population
- Time and location: 10:30 a.m. – 10:41 a.m. / Presentation Theater 3, Room 215, Level 2, Moscone South
Tuesday, Oct. 24:
Shockwave Medical Sponsored Symposia
- Presentation Title: The COSIRA-II Trial: Designed To Demonstrate Refractory Angina Relief with the Coronary Sinus Reducer
- Time and location: 2 p.m. – 3 p.m. / Presentation Theater 1, Room 205, Level 2, Moscone South
Wednesday, Oct. 25:
Shockwave Medical Sponsored Symposia
- Presentation Title: TOPSHOCK: Vote for this Year’s Best Coronary IVL Case
- Time and location: 11 a.m. – 12 p.m. / Presentation Theater 1, Room 205, Level 2, Moscone South
Thursday, Oct. 26:
Coronary Spotlight Session: Calcium – How Hard Should We Try?
- Presentation Title: Coronary IVL in the US: Trends, Hospital Variation, & Predictors of Use: Insights From the ACC NCDR CathPCI Registry
- Time and location: 10:42 a.m. – 10:50 a.m. / Coronary Spotlight Theater, Hall E, Exhibition Level, Moscone North
Shockwave Medical Sponsored Symposia
- Presentation Title: Coronary IVL: More Pulses, More Data, More Insights
- Time and location: 12:45 p.m. – 1:45 p.m. / Presentation Theater 2, Room 208, Level 2, Moscone South
Click here for additional information about TCT 2023, which runs Oct. 23-26, 2023.
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.